Method for treating mental retardation
Patent 6034108 Issued on March 7, 2000. Estimated Expiration Date: 
December 16, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 16, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPiperidine compounds and their preparation and use Piperidine compounds and their preparation and use Heterocyclic compounds and use Heterocyclic compounds and their use Method for treating anxiety Method for treating anxiety Patent #: 5708014 InventorsAssigneeApplicationNo. 202519 filed on 12/16/1998US Classes:514/342Ring sulfur in the additional hetero ringExaminersPrimary: Henley, III, RaymondAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/44AbstractThe present invention is directed to a method for using 3-(4-hexyloxy-1,2,5-thiadiazol-3yl)-1,2,5,6-tetrahydro-1-methylpyridine, i.e., xanomeline, for the treatment of autism and mental retardation.Other References
Field of SearchRing sulfur in the additional hetero ring | |
